Mohammad Abu Zaid (Mohammad I Abu Zaid)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Top Venues

Nature communications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Research square

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Travis S Johnson, Parvathi Sudha, Enze Liu, Nathan Becker, Sylvia Robertson, Patrick Blaney, Gareth J Morgan, Vivek S Chopra, Cedric Dos Santos, Michael Nixon, Kun Huang, Attaya Suvannasankha, Mohammad Abu Zaid, Rafat Abonour, Brian A Walker
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma. Nature communications 15 (1) (2024)
Travis S Johnson, Parvathi Sudha, Enze Liu, Nathan Becker, Sylvia Robertson, Patrick Blaney, Gareth J Morgan, Vivek S Chopra, Cedric Dos Santos, Michael Nixon, Kun Huang, Attaya Suvannasankha, Mohammad Abu Zaid, Rafat Abonour, Brian A Walker
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma. Nature communications 15 (1) (2024)
Travis S Johnson, Parvathi Sudha, Enze Liu, Nathan Becker, Sylvia Robertson, Patrick Blaney, Gareth J Morgan, Vivek S Chopra, Cedric Dos Santos, Michael Nixon, Kun Huang, Attaya Suvannasankha, Mohammad Abu Zaid, Rafat Abonour, Brian A Walker
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma. Nature communications 15 (1) (2024)
Travis S Johnson, Parvathi Sudha, Enze Liu, Nathan Becker, Sylvia Robertson, Patrick Blaney, Gareth J Morgan, Vivek S Chopra, Cedric Dos Santos, Michael Nixon, Kun Huang, Attaya Suvannasankha, Mohammad Abu Zaid, Rafat Abonour, Brian A Walker
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma. Nature communications 15 (1) (2024)
Travis S Johnson, Parvathi Sudha, Enze Liu, Nathan Becker, Sylvia Robertson, Patrick Blaney, Gareth J Morgan, Vivek S Chopra, Cedric Dos Santos, Michael Nixon, Kun Huang, Attaya Suvannasankha, Mohammad Abu Zaid, Rafat Abonour, Brian A Walker
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma. Nature communications 15 (1) (2024)
David Bernard Miklos, Mohammad Abu Zaid, Julian P Cooney, Jörn C Albring, Mary Evelyn Flowers, Alan P Skarbnik, Ibrahim Yakoub-Agha, Bor-Sheng Ko, Benedetto Bruno, Edmund K Waller, Jean A Yared, Sang Kyun Sohn, Claude-Eric Bulabois, Takanori Teshima, David Jacobsohn, Hildegard Greinix, Ahmad Mokatrin, Yihua Lee, Justin T Wahlstrom, Lori Styles, Gerard Sociè
Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Brian A Walker, Travis S Johnson, Parvathi Sudha, Enze Liu, Patrick Blaney, Gareth J Morgan, Vivek Chopra, Cedric Dos Santos, Michael Nixon, Kun Huang, Attaya Suvannasankha, Mohammad Abu Zaid, Rafat Abonour
Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myeloma. Research square (2023)
Enze Liu, Parvathi Sudha, Nathan Becker, Oumaima Jaouadi, Attaya Suvannasankha, Kelvin Lee, Rafat Abonour, Mohammad Abu Zaid, Brian A Walker
Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma. Blood cancer journal 13 (1) (2023)
Parvathi Sudha, Aarif Ahsan, Timothy Cody Ashby, Tasneem Kausar, Akhil Khera, Mohammad H Kazeroun, Chih-Chao Hsu, Lin Wang, Evelyn Fitzsimons, Outi Salminen, Patrick Blaney, Magdalena Czader, Jonathan Williams, Mohammad Abu Zaid, Naser Ansari-Pour, Kwee L Yong, Frits van Rhee, William E Pierceall, Gareth J Morgan, Erin Flynt, Sarah Gooding, Rafat Abonour, Karthik Ramasamy, Anjan Thakurta, Brian A Walker
Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (13) (2022)
Carrie L Kitko, Mukta Arora, Zachariah DeFilipp, Mohammad Abu Zaid, Antonio Di Stasi, Vedran Radojcic, Courtney B Betts, Lisa M Coussens, Michael L Meyers, Hope Qamoos, Peter Ordentlich, Vinit Kumar, Christine Quaranto, Aaron Schmitt, Yu Gu, Bruce R Blazar, Trent P Wang, Amandeep Salhotra, Iskra Pusic, Madan Jagasia, Stephanie J Lee
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Vaibhav Agrawal, Praveen Ranganath, Kirsten D Ervin, Caitlin A Schmidt, Elizabeth A Cox, Robert P Nelson, Jennifer E Schwartz, Mohammad Abu Zaid, Rafat Abonour, Michael J Robertson, Bryan J Brinda, Shawn P Griffin, Teresa C Thakrar, Sherif S Farag
Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome. Bone marrow transplantation 56 (1) (2020)
Sophie Paczesny, Mohammad Abu Zaid
CXCL10: most consistent cGVHD biomarker? Blood 127 (24) (2018)